Delivery Order SPE2DB24D8001-SPE2DB25FKZUL
Award Date 5/30/25
Potential Completion Date 6/2/25
Potential Value $3.3K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Anoka, MN, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- Dakota Drug, Inc., a self-certified small disadvantaged business based in Anoka, Minnesota, was awarded a delivery order valued at $2,308.14 by the Defense Logistics Agency (DLA) on June 2, 2025, with an ultimate completion date of June 2, 2025. This Firm Fixed Price delivery order, issued without set-aside designation, represents a task order under Dakota Drug's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical's ECAT Generation V Program, valued at $999,999,999.00 and...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract, valued at $15,860.63, is for the delivery of pharmaceutical products, medical supplies, and healthcare equipment to support U.S. Armed Forces medical operations. The contract has an ultimate completion date of March 20, 2025. Dakota Drug, Inc. holds a larger Indefinite Delivery Contract (IDC) with the DLA, valued at...
- This contract award to Dakota Drug, Inc., a self-certified small disadvantaged business, is a firm fixed-price delivery order from the Defense Logistics Agency (DLA) Troop Support Medical for the supply of pharmaceutical products, including prescription medications such as insulin pens, inhalers, anticoagulants, and biologic drugs. The contract, valued at $11,449.29, has an ultimate completion date of September 4, 2024 and is not designated as a set-aside contract. Dakota Drug, Inc. holds a...
- This federal contract award, identified as SPE2DB24D8002/SPE2DB25FJNJD, was issued by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The $4,790.02 firm fixed-price delivery order is for the supply of QULIPTA 60 MG TABLET 30S, a pharmaceutical product, with a performance period through March 20, 2025. Dakota Drug, Inc. holds a significant single-award Indefinite Delivery Contract (IDC) with the DLA, identified as SPE2DB24D8001, valued at...
- This federal contract award to Dakota Drug, Inc., a self-certified small disadvantaged business, was issued by the Defense Logistics Agency (DLA) for the delivery of pharmaceutical products, medical supplies, and healthcare equipment to support U.S. Armed Forces medical operations. The award, valued at $3,457.84, is a delivery order under the company's $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA, which is part of the DLA Troop Support Medical's ECAT Generation V Program. This...
- This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business located in Anoka, Minnesota. The contract is for the supply of pharmaceutical products, medical supplies, and healthcare equipment, with a focus on supporting U.S. Armed Forces medical operations. The contract has a ceiling value of $3,151.10 and an ultimate completion date of May 8, 2025. It is part of the DLA Troop Support Medical's ECAT Generation...
- The U.S. Defense Logistics Agency (DLA) awarded a $1,699.40 firm-fixed-price delivery order to Dakota Drug, Inc., a self-certified small disadvantaged business located in Anoka, Minnesota. This delivery order, which was not set aside, is part of a larger Indefinite Delivery Contract (IDC) identified as SPE2DB24D8001, valued at $999,999,999.00. The IDC allows Dakota Drug to provide a comprehensive range of pharmaceutical products, medical supplies, and healthcare equipment to support U.S. Armed...
- The Defense Logistics Agency awarded a delivery order valued at $1,873.31 to Dakota Drug, Inc., a small disadvantaged business based in Anoka, Minnesota, for the supply of Mounjaro 15 mg/0.5 mL pen injections. The contract, issued on August 5, 2025, with an ultimate completion date of August 6, 2025, operates under a firm fixed price structure with no set-aside designation. This delivery order is issued under Dakota Drug's larger Indefinite Delivery Contract (SPE2DB24D8001) with DLA Troop...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business located in Anoka, Minnesota. The contract is part of the DLA Troop Support Medical's ECAT Generation V Program and has a ceiling value of $3,679.78. It covers the delivery of PROQUAD VIALS, a pharmaceutical product, through June 4, 2025. Dakota Drug, Inc. holds a larger Indefinite Delivery Contract (IDC) with the DLA, valued at $999,999,999.00, which...
- Dakota Drug, Inc., a self-certified small disadvantaged business based in Anoka, Minnesota, was awarded a delivery order by the Defense Logistics Agency (DLA) on August 13, 2025, for the supply of Methylphenidate ER 36 mg tablets in quantities of 100 units. This firm fixed-price delivery order, valued at $6,484.12, is scheduled for completion by August 14, 2025, and represents performance work to be conducted at the contractor's Anoka, Minnesota location. The award utilized no set-aside...